Afinitor iimage

Novartis’ Afinitor fails NICE test

July 8, 2013
Sales and Marketing Afinitor, NHS, NICE, Novartis

Novartis’ breast cancer drug Afinitor (everolimus) has been knocked back by NICE as “it is not good value for money”. …

Focus image Ben

A word from the new editor

July 8, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, Pharmafocus, pharmafile

My name is Ben Adams, and I have the honour and the responsibility of becoming the new editor at Pharmafocus.I …

screen_shot_2013-07-08_at_08

Life Healthcare appoints senior account manager

July 8, 2013
Medical Communications, Sales and Marketing Life Healthcare

Creative comms agency Life Healthcare Communications is developing its client services team further with the appointment of a new senior account …

Minister: ‘Prosecute NHS directors’

July 5, 2013
Sales and Marketing CQC, DoH, Lamb, Mid Staffs, NHS

Directors responsible for failures in care such as those seen at the Mid Staffordshire NHS Foundation Trust should face prosecution, …

Bowel cancer screening image

Bowel cancer surgery ‘increases chances’

July 5, 2013
Sales and Marketing HSCIC, NHS, bowel cancer

Having surgery to treat bowel cancer massively increases a patient’s chance of survival, according to data from a new national …

ian_hudson

New MHRA chief executive named

July 5, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MHRA, ian hudson

The Department of Health has announced the appointment of Dr Ian Hudson as chief executive of the Medicines and Healthcare …

Manufacturing and production news in brief

July 5, 2013
Manufacturing and Production Almac, Elona Biotech, Kamada, King Pharmaceuticals, Shasun Pharma, Tianyin Pharma

A round-up of recent developments in the pharma manufacturing sector, including a fine for King Pharma, a strike at a …

EPPA image

Tighter rules on pharma gifts challenged by manufacturers

July 4, 2013
Manufacturing and Production, Medical Communications, Sales and Marketing EFPIA, EPPA, promotional products, transparency

The pharma industry could face a series of lawsuits by manufacturers of promotional gifts as new rules look to ban …

GSK image

GSK under investigation in China

July 4, 2013
Sales and Marketing China, GSK, NDRC, corruption

GlaxoSmithKline is being investigated by authorities in China in what appear to be two separate probes into the UK manufacturer’s …

EFPIA image

Pharma to disclose doctor payments

July 4, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, pharma, transparency

Pharma companies in Europe will have to reveal how much they pay to doctors under a voluntary agreement set out …

Host of new hires at Tonic Life Communications

July 4, 2013
Medical Communications tonic communications

Tonic Life Communications has announced seven new hires to work on its global, European and UK client portfolio from its …

Packaging specialist Chesapeake sold to private equity firm

July 4, 2013
Manufacturing and Production Chesapeake, carlyle group, packaging

Packaging specialist Chesapeake has been sold to private equity firm Carlyle Group in a move designed to accelerate the company’s …

UK crackdown on ‘health tourism’

July 4, 2013
Sales and Marketing Hunt, NHS, doctors

The UK health secretary has unveiled new plans aimed at reducing the cost of providing care to immigrants on the …

Glass contamination prompts Fresenius recall

July 4, 2013
Manufacturing and Production Fresenius, recall

The US subsidiary of German drugmaker Fresenius has recalled a drug used in the treatment of Parkinson’s disease because of …

prof_brendan_buckley

ICON appoints chief medical officer

July 4, 2013
Manufacturing and Production, Research and Development, Sales and Marketing EMA, ICON, buckley

Clinical research organisation ICON has confirmed the appointment of Professor Brendan Buckley as chief medical officer. Buckley will be ICON’s …

Roche leukaemia drug granted speedy US review

July 3, 2013
Research and Development, Sales and Marketing CLL, FDA, Roche, leukaemia, obinutuzumab

Roche’s investigational leukaemia drug could be available for US patients by the end of the year as the FDA looks …

fda image

FDA gives Perjeta priority

July 3, 2013
Sales and Marketing FDA, Perjeta, Roche, breast cancer

The FDA has granted priority review status to an application for Roche’s Perjeta to be used before surgery in HER2-positive …

Merck Serono sets up cancer platform

July 3, 2013
Research and Development, Sales and Marketing Cancer, Cladribine, Merck Serono, kgaa

Merck Serono is attempting to speed up R&D on products which stimulate the immune system to fight cancer by establishing …

sam_ng

RSA makes series of appointments

July 3, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing rsa

Life Sciences Executive Search and Interim Management firm RSA has made a series of appointments across the company. Codrina Schech …

EMA approves extended Xaluprine shelf life

July 2, 2013
Manufacturing and Production, Research and Development

The European Medicines Agency (EMA) has approved an extension of the in-use shelf life for Xaluprine – a liquid formulation …

The Gateway to Local Adoption Series

Latest content